#3d bioprinting
Discover 2 curated intelligence briefings related to this specific topic.
Science & Health
The Biohybrid Mirage: Why Synthetic Organs Won't Clear the Waitlist
17 people die every day waiting for a transplant. The industry sells biohybrid substrates as the cure. It is a curated lie based on lab-scale wins and ignored failure rates.
Read Analysis
Technology & Innovation
Biopharma is Trading Pills for Printed Organs
As blockbuster drug patents expire, pharmaceutical giants are shifting capital toward 3D bioprinting to build a new, uncopyable moat of biological intellectual property.
Read Analysis